• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大麻二酚与酒精使用障碍相关潜在神经生物学机制的神经影像学研究:一项系统综述。

Neuroimaging studies of cannabidiol and potential neurobiological mechanisms relevant for alcohol use disorders: a systematic review.

作者信息

Hurzeler Tristan, Watt Joshua, Logge Warren, Towers Ellen, Suraev Anastasia, Lintzeris Nicholas, Haber Paul, Morley Kirsten C

机构信息

Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.

Translational Research in Alcohol, Edith Collins Centre, Sydney Local Health District, Sydney, Australia.

出版信息

J Cannabis Res. 2024 Mar 21;6(1):15. doi: 10.1186/s42238-024-00224-0.

DOI:10.1186/s42238-024-00224-0
PMID:38509580
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10956336/
Abstract

The underlying neurobiological mechanisms of cannabidiol's (CBD) management of alcohol use disorder (AUD) remains elusive.Aim We conducted a systematic review of neuroimaging literature investigating the effects of CBD on the brain in healthy participants. We then theorise the potential neurobiological mechanisms by which CBD may ameliorate various symptoms of AUD.Methods This review was conducted according to the PRISMA guidelines. Terms relating to CBD and neuroimaging were used to search original clinical research published in peer-reviewed journals.Results Of 767 studies identified by our search strategy, 16 studies satisfied our eligibility criteria. The results suggest that CBD modulates γ-Aminobutyric acid and glutamate signaling in the basal ganglia and dorso-medial prefrontal cortex. Furthermore, CBD regulates activity in regions associated with mesocorticolimbic reward pathways; salience, limbic and fronto-striatal networks which are implicated in reward anticipation; emotion regulation; salience processing; and executive functioning.Conclusion CBD appears to modulate neurotransmitter systems and functional connections in brain regions implicated in AUD, suggesting CBD may be used to manage AUD symptomatology.

摘要

大麻二酚(CBD)对酒精使用障碍(AUD)的潜在神经生物学机制仍不清楚。目的我们对神经影像学文献进行了系统综述,研究CBD对健康参与者大脑的影响。然后,我们对CBD可能改善AUD各种症状的潜在神经生物学机制进行了理论推测。方法本综述按照PRISMA指南进行。使用与CBD和神经影像学相关的术语检索发表在同行评审期刊上的原始临床研究。结果通过我们的检索策略识别出的767项研究中,16项研究符合我们的纳入标准。结果表明,CBD调节基底神经节和背内侧前额叶皮质中的γ-氨基丁酸和谷氨酸信号传导。此外,CBD调节与中脑边缘奖赏通路、与奖赏预期、情绪调节、显著性处理和执行功能有关的显著性、边缘和额纹状体网络相关区域的活动。结论CBD似乎调节了与AUD相关的脑区中的神经递质系统和功能连接,表明CBD可用于管理AUD症状。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/242c/10956336/a8aa645d4fa2/42238_2024_224_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/242c/10956336/788be53a2175/42238_2024_224_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/242c/10956336/a8aa645d4fa2/42238_2024_224_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/242c/10956336/788be53a2175/42238_2024_224_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/242c/10956336/a8aa645d4fa2/42238_2024_224_Fig2_HTML.jpg

相似文献

1
Neuroimaging studies of cannabidiol and potential neurobiological mechanisms relevant for alcohol use disorders: a systematic review.大麻二酚与酒精使用障碍相关潜在神经生物学机制的神经影像学研究:一项系统综述。
J Cannabis Res. 2024 Mar 21;6(1):15. doi: 10.1186/s42238-024-00224-0.
2
The Impact of Cannabidiol on Human Brain Function: A Systematic Review.大麻二酚对人类脑功能的影响:一项系统评价
Front Pharmacol. 2021 Jan 21;11:618184. doi: 10.3389/fphar.2020.618184. eCollection 2020.
3
Brain Correlates of the Alcohol Use Disorder Pharmacotherapy Response: A Systematic Review of Neuroimaging Studies.酒精使用障碍药物治疗反应的脑关联:神经影像学研究的系统综述
Brain Sci. 2022 Mar 14;12(3):386. doi: 10.3390/brainsci12030386.
4
The impact of cannabidiol treatment on resting state functional connectivity, prefrontal metabolite levels and reward processing in recent-onset patients with a psychotic disorder.大麻二酚治疗对首发精神病患者静息态功能连接、前额叶代谢物水平和奖赏处理的影响。
J Psychiatr Res. 2023 Jul;163:93-101. doi: 10.1016/j.jpsychires.2023.05.019. Epub 2023 May 13.
5
The Yin and Yang of Cannabis: A Systematic Review of Human Neuroimaging Evidence of the Differential Effects of Δ-Tetrahydrocannabinol and Cannabidiol.大麻的阴阳两面:Δ-四氢大麻酚和大麻二酚对人类神经影像学影响差异的系统评价。
Biol Psychiatry Cogn Neurosci Neuroimaging. 2021 Jun;6(6):636-645. doi: 10.1016/j.bpsc.2020.10.007. Epub 2020 Oct 27.
6
Cannabidiol as a Novel Candidate Alcohol Use Disorder Pharmacotherapy: A Systematic Review.大麻二酚作为一种新型候选酒精使用障碍药物治疗:系统评价。
Alcohol Clin Exp Res. 2019 Apr;43(4):550-563. doi: 10.1111/acer.13964. Epub 2019 Feb 19.
7
The neurobehavioural effects of cannabidiol in alcohol use disorder: Study protocol for a double-blind, randomised, cross over, placebo-controlled trial.大麻二酚对酒精使用障碍的神经行为影响:一项双盲、随机、交叉、安慰剂对照试验的研究方案。
Contemp Clin Trials Commun. 2024 Aug 13;41:101341. doi: 10.1016/j.conctc.2024.101341. eCollection 2024 Oct.
8
Cannabidiol attenuates insular activity during motivational salience processing in patients with early psychosis.大麻二酚可减轻早期精神病患者在动机显著性处理期间的岛叶活动。
Psychol Med. 2023 Jul;53(10):4732-4741. doi: 10.1017/S0033291722001672. Epub 2022 Jul 1.
9
Probing the endocannabinoid system in healthy volunteers: Cannabidiol alters fronto-striatal resting-state connectivity.在健康志愿者中探测内源性大麻素系统:大麻二酚改变额-纹状体静息状态连通性。
Eur Neuropsychopharmacol. 2018 Jul;28(7):841-849. doi: 10.1016/j.euroneuro.2018.04.004. Epub 2018 Jun 7.
10
Effect of cannabidiol on endocannabinoid, glutamatergic and GABAergic signalling markers in male offspring of a maternal immune activation (poly I:C) model relevant to schizophrenia.母体免疫激活(poly I:C)模型相关精神分裂症雄性子代中大麻二酚对内源性大麻素、谷氨酸能和 GABA 能信号标志物的影响。
Prog Neuropsychopharmacol Biol Psychiatry. 2019 Dec 20;95:109666. doi: 10.1016/j.pnpbp.2019.109666. Epub 2019 Jun 14.

引用本文的文献

1
CBD attenuates amygdala response to negative emotional stimuli in individuals with alcohol use disorder - a randomized controlled trial.大麻二酚可减轻酒精使用障碍个体杏仁核对负面情绪刺激的反应——一项随机对照试验。
Psychopharmacology (Berl). 2025 Aug 29. doi: 10.1007/s00213-025-06860-5.
2
The neurobehavioural effects of cannabidiol in alcohol use disorder: Study protocol for a double-blind, randomised, cross over, placebo-controlled trial.大麻二酚对酒精使用障碍的神经行为影响:一项双盲、随机、交叉、安慰剂对照试验的研究方案。
Contemp Clin Trials Commun. 2024 Aug 13;41:101341. doi: 10.1016/j.conctc.2024.101341. eCollection 2024 Oct.

本文引用的文献

1
Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis.大麻二酚治疗儿科难治性癫痫适应证的临床疗效和安全性:系统评价和荟萃分析。
Exp Neurol. 2023 Jan;359:114238. doi: 10.1016/j.expneurol.2022.114238. Epub 2022 Oct 4.
2
Cannabidiol for Treatment-Resistant Anxiety Disorders in Young People: An Open-Label Trial.大麻二酚治疗青少年治疗抵抗性焦虑障碍:一项开放性试验。
J Clin Psychiatry. 2022 Aug 3;83(5):21m14130. doi: 10.4088/JCP.21m14130.
3
Effects of cannabidiol on simulated driving and cognitive performance: A dose-ranging randomised controlled trial.
大麻二酚对模拟驾驶和认知表现的影响:一项剂量范围随机对照试验。
J Psychopharmacol. 2022 Dec;36(12):1338-1349. doi: 10.1177/02698811221095356. Epub 2022 May 30.
4
Individual and combined effects of cannabidiol and Δ-tetrahydrocannabinol on striato-cortical connectivity in the human brain.大麻二酚和 Δ-四氢大麻酚对人脑纹状体-皮质连接的单独和联合作用。
J Psychopharmacol. 2022 Jun;36(6):732-744. doi: 10.1177/02698811221092506. Epub 2022 May 20.
5
The acute effects of cannabidiol on emotional processing and anxiety: a neurocognitive imaging study.大麻二酚对情绪处理和焦虑的急性影响:一项神经认知成像研究。
Psychopharmacology (Berl). 2022 May;239(5):1539-1549. doi: 10.1007/s00213-022-06070-3. Epub 2022 Apr 21.
6
New Australian guidelines for the treatment of alcohol problems: an overview of recommendations.澳大利亚新的酒精问题治疗指南:推荐意见概述。
Med J Aust. 2021 Oct 4;215 Suppl 7:S3-S32. doi: 10.5694/mja2.51254.
7
Altered relationship between cortisol response to social stress and mediotemporal function during fear processing in people at clinical high risk for psychosis: a preliminary report.临床精神病高危人群在恐惧处理过程中,社会应激后皮质醇反应与中颞叶功能之间关系的改变:初步报告。
Eur Arch Psychiatry Clin Neurosci. 2022 Apr;272(3):461-475. doi: 10.1007/s00406-021-01318-z. Epub 2021 Sep 4.
8
A placebo-controlled investigation of the analgesic effects, abuse liability, safety and tolerability of a range of oral cannabidiol doses in healthy humans.一项安慰剂对照研究,评估了一系列口服大麻二酚剂量在健康人群中的镇痛效果、滥用倾向、安全性和耐受性。
Br J Clin Pharmacol. 2022 Jan;88(1):347-355. doi: 10.1111/bcp.14973. Epub 2021 Jul 23.
9
The (Poly)Pharmacology of Cannabidiol in Neurological and Neuropsychiatric Disorders: Molecular Mechanisms and Targets.大麻素在神经和神经精神疾病中的(多)药理学:分子机制和靶点。
Int J Mol Sci. 2021 May 5;22(9):4876. doi: 10.3390/ijms22094876.
10
Commentary on Donoghue: Low prescribing rates of pharmacotherapy for alcohol use disorder limit potential public health impact.关于多诺霍的评论:酒精使用障碍药物治疗的低处方率限制了潜在的公共卫生影响。
Addiction. 2021 Nov;116(11):3027-3028. doi: 10.1111/add.15532. Epub 2021 May 11.